anonymous
Guest
anonymous
Guest
The few products driving the business at Genentech are not therapeutic areas which benefit from the ecosystem model. Why can’t Roche/ Genentech admit this field structure does NOT work in many therapeutic areas. The pipeline products don’t fit either! The longer you wait to dismantle this mess, the worse it gets. Be honest and look at the disconnect. No other companies will follow because they see how badly it hurts business. It’s the MODEL not the people. Look around. Use business sense! The field is afraid to speak up due to threats from HEDs and HDs. They know their jobs will be “at risk” if the old model is brought back. This company has been destroyed by horrible CEOs with very bad ideas. Ashley, will you be different?